KRAS and cancer: Rhox5 is expressed not only in established cancer cell lines [13-15], but also in cancers in vivo, e.g., adenomas and carcinomas in the APCMin/+ mice and large intestine tumors of Msh2-deficient mice conditionally expressing K-ras (V12) [16,17].